Summit Therapeutics Inc. - Common Stock (SMMT)

Summit Therapeutics is a biotechnology company focused on the discovery and development of novel antibiotic therapies

The company specializes in addressing complex infectious diseases, particularly those caused by antibiotic-resistant bacteria. Summit Therapeutics leverages its proprietary drug development platform to create innovative treatments aimed at improving patient outcomes and combating the growing threat of antibiotic resistance. Through its research and clinical programs, the company seeks to bring forward effective solutions to meet unmet medical needs in the realm of infectious diseases.